• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VYGON UMBILICA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VYGON UMBILICA CATHETER Back to Search Results
Model Number 1272.04
Device Problems Fluid/Blood Leak (1250); Patient Device Interaction Problem (4001); Migration (4003)
Patient Problems Death (1802); Extravasation (1842); Renal Failure (2041)
Event Date 01/12/2020
Event Type  Death  
Manufacturer Narrative
The failed sample will be returned to vygon for device evaluation as part of the complaint investigation.The results of this investigation are still pending, and will be communicated to fda within 30 days of its conclusion.
 
Event Description
(b)(6) week gestation infant born on (b)(6).Umbilical venous catheter inserted on the day of birth.On (b)(6) referred from hospital to (b)(6) with an acute abdomen.Tpn extravasation diagnosed at (b)(6) secondary to liver and abdominal extravasation of tpn from umbilical venous catheter.Drained soon after admission to (b)(6) with surgical peritoneal drain.Umbilical catheter removed.This catheter stays 5 days in situ.Baby subsequently went on to develop intractable renal failure and necrotising enterocolitis with perforation needing laparotomy.Palliative care commenced and intensive care withdrawn on the (b)(6).Baby died on (b)(6) 2020.
 
Manufacturer Narrative
We have received the involved umbilical catheter.During the investigation, the returned device functioned normally, with no signs of leakage identified when flushing either lumen of the device.Unfortunately, we are unaware as to how the location of the device was confirmed after placement.The instructions for use (ifu) provided with the device advise: "control of positioning: always check the location of the catheter by radiography.For umbilical arterial catheterization, the catheter can be sited either in the high position between thoracic vertebrae t6 and t9 or the low position at l3 to l5 level though the higher position is associated with lower complication rates.For umbilical venous catheterization, the catheter tip should be placed beyond the ductus venosus in the central venous system (inferior vena cava)." the returned catheter is conform, there is no defect.On evaluation of our historical datas since 2017, we can confirm that we have not received any additional reports of a similar nature for this product.The root cause of this adverse event is not linked to the quality of our device.
 
Event Description
(b)(6) gestation infant born on (b)(6).Umbilical venous catheter inserted on the day of birth.On (b)(6) referred from hospital to (b)(6) with an acute abdomen.Tpn extravasation diagnosed at (b)(6) to liver and abdominal extravasation of tpn from umbilical venous catheter.Drained soon after admission to (b)(6) with surgical peritoneal drain.Umbilical catheter removed.This catheter stays 5 days in situ.Baby subsequently went on to develop intractable renal failure and necrotising enterocolitis with perforation needing laparotomy.Palliative care commenced and intensive care withdrawn on the (b)(6).Baby died on (b)(6) 2020.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UMBILICA CATHETER
Type of Device
UMBILICA CATHETER
Manufacturer (Section D)
VYGON
5 rue adeline
ecouen 95440
FR  95440
Manufacturer (Section G)
VYGON
5 rue adeline
ecouen 95440
FR   95440
Manufacturer Contact
freda lacroix
2750 morris road
lansdale, pa 
4735414237
MDR Report Key9720395
MDR Text Key179783718
Report Number2245270-2020-00008
Device Sequence Number1
Product Code FOS
Combination Product (y/n)N
PMA/PMN Number
K981630
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 04/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/18/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Model Number1272.04
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Yes
Date Manufacturer Received02/05/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age29 WK
-
-